glp-1 weight loss timeline of critical milestones in the development and use of What are GLP-1s? | Mendinground
Description
Other trials also reported a reduction in body weight, HbA1c, and FPG in patients receiving combination therapy with SGLT-2i plus GLP-1RA [9, 23, 46]
In 2021, the results of a meta-analysis that included 7 RCT studies showed that GLP-RA uses resulted in a decreased risk of respiratory disease [43]
There have been postmarketing reports of severe and disabling arthralgia in patients taking DPP-4 inhibitors
However, they are serious and should be factored into the riskbenefit discussion when considering GLP-1 therapy with a doctor
doi: 10.1016/j.jad.2018.04.042
